AlloVir, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 30.3 million compared to USD 41.18 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.44 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7836 USD | +2.48% | +5.74% | +15.11% |
05-13 | AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-20 | North American Morning Briefing : Markets on Hold -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 86.73M | |
+18.45% | 123B | |
+15.11% | 107B | |
-4.68% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.66% | 16.23B | |
+2.45% | 13.43B | |
+24.17% | 11.32B |
- Stock Market
- Equities
- ALVR Stock
- News AlloVir, Inc.
- AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024